• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声心动图与患者报告的心脏再同步治疗反应之间的差异:PSYHEART-CRT 研究结果。

Discrepancy between echocardiographic and patient-reported health status response to cardiac resynchronization therapy: results of the PSYHEART-CRT study.

机构信息

CoRPS-Center of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Eur J Heart Fail. 2014 Feb;16(2):227-34. doi: 10.1002/ejhf.38. Epub 2013 Dec 11.

DOI:10.1002/ejhf.38
PMID:24464983
Abstract

AIMS

The current study examined the degree of agreement between echocardiographic and patient-reported health status response to CRT 6 months after implantation, and evaluated the differences in pre-implantation characteristics of patients with concordant and discordant echocardiographic and health status responses.

METHODS AND RESULTS

Consecutively implanted CRT-defibrillator patients (n = 109, mean age = 65.4 ± 10.1 years, 74 men) were recruited from the University Medical Center Utrecht, The Netherlands. Prior to implantation and 6 months post-implantation, all patients underwent echocardiography and completed the Kansas City Cardiomyopathy Questionnaire (KCCQ). Echocardiographic response was defined as a relative reduction of ≥15% in LV end-systolic volume; an improvement of ≥10 points in KCCQ score indicated a health status response. In the 54 patients with discordant responses, 25 (22.9%) had an echocardiographic response but no health status response and 29 (26.6%) had a health status response but no echocardiographic response. Patients with concordant and discordant responses differed on various pre-implantation characteristics, including sex, employment status, LV volumes, and pre-implantation KCCQ score. In multivariable analysis, pre-implantation KCCQ score [odds ratio (OR) = 0.91, 95% confidence interval (CI) = 0.88-0.95, P < 0.001] and QRS duration (OR = 1.03, 95% CI = 1.01-1.06, P = 0.009) were the only characteristics associated with health status response to CRT.

CONCLUSIONS

Our results show a large discrepancy between echocardiographic and patient-reported health status response to CRT. The most important predictor of health status response was the pre-implantation health status score. These results emphasize that disease-specific health status measures may have additional value over 'objective' measures of CRT response and should be incorporated in clinical practice.

摘要

目的

本研究旨在评估 CRT 植入后 6 个月时超声心动图与患者报告的健康状况之间的一致性程度,并评估具有一致性和不一致性超声心动图与健康状况反应的患者在植入前特征上的差异。

方法和结果

从荷兰乌得勒支大学医学中心连续招募 CRT 除颤器植入患者(n=109,平均年龄 65.4±10.1 岁,74 名男性)。在植入前和植入后 6 个月,所有患者均接受超声心动图检查并完成堪萨斯城心肌病问卷(KCCQ)。超声心动图反应定义为 LV 收缩末期容积相对减少≥15%;KCCQ 评分改善≥10 分表明健康状况有反应。在 54 例反应不一致的患者中,25 例(22.9%)有超声心动图反应但无健康状况反应,29 例(26.6%)有健康状况反应但无超声心动图反应。具有一致性和不一致性反应的患者在各种植入前特征上存在差异,包括性别、就业状况、LV 容积和植入前 KCCQ 评分。多变量分析显示,植入前 KCCQ 评分[比值比(OR)=0.91,95%置信区间(CI)=0.88-0.95,P<0.001]和 QRS 持续时间(OR=1.03,95%CI=1.01-1.06,P=0.009)是 CRT 对健康状况反应的唯一特征。

结论

我们的结果表明,超声心动图与患者报告的 CRT 健康状况反应之间存在较大差异。健康状况反应的最重要预测因素是植入前的健康状况评分。这些结果强调,特定疾病的健康状况测量可能比 CRT 反应的“客观”测量具有额外的价值,应纳入临床实践。

相似文献

1
Discrepancy between echocardiographic and patient-reported health status response to cardiac resynchronization therapy: results of the PSYHEART-CRT study.超声心动图与患者报告的心脏再同步治疗反应之间的差异:PSYHEART-CRT 研究结果。
Eur J Heart Fail. 2014 Feb;16(2):227-34. doi: 10.1002/ejhf.38. Epub 2013 Dec 11.
2
Echocardiographic dyssynchrony and health status outcomes from cardiac resynchronization therapy: insights from the PROSPECT trial.超声心动图不同步与心脏再同步治疗的健康状况结局:来自 PROSPECT 试验的观察。
JACC Cardiovasc Imaging. 2010 May;3(5):451-60. doi: 10.1016/j.jcmg.2009.08.012.
3
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).比较低脉压(<40mmHg)与高脉压(>40mmHg)对预测心力衰竭心脏再同步治疗获益的价值(来自多中心自动除颤器植入试验-心脏再同步治疗试验)。
Am J Cardiol. 2014 Oct 1;114(7):1053-8. doi: 10.1016/j.amjcard.2014.07.014. Epub 2014 Jul 17.
4
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).心脏再同步治疗的多中心自动除颤器植入试验(MADIT-CRT)中对心脏再同步治疗反应的预测因素。
Circulation. 2011 Oct 4;124(14):1527-36. doi: 10.1161/CIRCULATIONAHA.110.014324. Epub 2011 Sep 6.
5
Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.心脏再同步治疗超级反应的预测因素及其对临床结局的改善:MADIT-CRT(心脏再同步治疗的多中心自动除颤器植入试验)研究。
J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73. doi: 10.1016/j.jacc.2012.01.065.
6
Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival.心脏再同步治疗的临床和超声心动图反应对长期生存的影响。
Eur Heart J Cardiovasc Imaging. 2013 Aug;14(8):774-81. doi: 10.1093/ehjci/jes290. Epub 2012 Dec 7.
7
Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.心脏再同步治疗除颤器植入对轻至中度心力衰竭症状患者健康状况的影响。
Am J Cardiol. 2011 Oct 15;108(8):1155-9. doi: 10.1016/j.amjcard.2011.06.019. Epub 2011 Aug 6.
8
Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.心脏再同步治疗后临床改善但左心室逆向重构不明显患者的患病率和特征。
Am Heart J. 2010 Oct;160(4):737-43. doi: 10.1016/j.ahj.2010.07.016.
9
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).多中心自动除颤器植入试验-心脏再同步治疗(MADIT-CRT)中 QRS 形态对心脏再同步治疗效果的影响。
Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.
10
Distinct trajectories of disease-specific health status in heart failure patients undergoing cardiac resynchronization therapy.接受心脏再同步治疗的心力衰竭患者特定疾病健康状况的不同轨迹。
Qual Life Res. 2016 Jun;25(6):1451-60. doi: 10.1007/s11136-015-1176-3. Epub 2015 Nov 13.

引用本文的文献

1
The Role of Echocardiography in the Optimization of Cardiac Resynchronization Therapy: Current Evidence and Future Perspectives.超声心动图在心脏再同步治疗优化中的作用:当前证据与未来展望
Open Cardiovasc Med J. 2017 Dec 19;11:133-145. doi: 10.2174/1874192401711010133. eCollection 2017.
2
Scar burden assessed by Selvester QRS score predicts prognosis, not CRT clinical benefit in preventing heart failure event and death: A MADIT-CRT sub-study.通过塞尔维斯特QRS评分评估的瘢痕负担可预测预后,但不能预测心脏再同步治疗(CRT)预防心力衰竭事件和死亡的临床获益:一项MADIT-CRT子研究。
J Electrocardiol. 2016 Jul-Aug;49(4):603-9. doi: 10.1016/j.jelectrocard.2016.04.008. Epub 2016 May 2.
3
Burdensome Physical and Depressive Symptoms Predict Heart Failure-Specific Health Status Over One Year.
繁重的身体症状和抑郁症状可预测一年以上的心力衰竭特异性健康状况。
J Pain Symptom Manage. 2016 Jun;51(6):963-70. doi: 10.1016/j.jpainsymman.2015.12.328. Epub 2016 Feb 26.
4
Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays.心脏再同步治疗前患者报告的健康状况可识别出生存率低和住院时间延长风险的患者。
Neth Heart J. 2016 Jan;24(1):18-24. doi: 10.1007/s12471-015-0775-5.
5
Echocardiography and cardiac resynchronisation therapy, friends or foes?超声心动图与心脏再同步治疗:是友还是敌?
Neth Heart J. 2016 Jan;24(1):25-38. doi: 10.1007/s12471-015-0769-3.
6
Distinct trajectories of disease-specific health status in heart failure patients undergoing cardiac resynchronization therapy.接受心脏再同步治疗的心力衰竭患者特定疾病健康状况的不同轨迹。
Qual Life Res. 2016 Jun;25(6):1451-60. doi: 10.1007/s11136-015-1176-3. Epub 2015 Nov 13.
7
Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome.心脏再同步治疗六个月以上的容积反应与临床结局
PLoS One. 2015 May 1;10(5):e0124323. doi: 10.1371/journal.pone.0124323. eCollection 2015.